Clinical Trial Update: Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial called Neo-PREDICT aims to predict how patients with breast cancer will respond to neoadjuvant endocrine therapy and is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: George Washington University | Conditions: Breast Cancer Stage I, Breast Cancer Stage II | Phase 2 | Status: RECRUITING